Menu Search
Equities

AngioDynamics Inc

ANGO:NSQ

AngioDynamics Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)7.00
  • Today's Change0.05 / 0.72%
  • Shares traded63.58k
  • 1 Year change+2.19%
  • Beta0.6780
Data delayed at least 15 minutes, as of Nov 22 2024 15:58 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year AngioDynamics Inc's revenues fell -10.28% from 338.75m to 303.91m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a loss of 52.44m to a larger loss of 184.35m.
Gross margin51.71%
Net profit margin-83.02%
Operating margin-82.18%
Return on assets-61.72%
Return on equity-77.85%
Return on investment-74.39%
More ▼

Cash flow in USDView more

In 2024, AngioDynamics Inc increased its cash reserves by 70.45%, or 31.44m. Cash Flow from Investing totalled 123.72m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 28.16m for operations while cash used for financing totalled 64.25m.
Cash flow per share-5.33
Price/Cash flow per share--
Book value per share4.79
Tangible book value per share2.95
More ▼

Balance sheet in USDView more

AngioDynamics Inc uses little or no debt in its capital structure.
Current ratio2.25
Quick ratio1.41
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.